Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BY.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BY.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BY.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.42ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.42NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAY.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAY.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.17.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.17.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.17.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.17.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used